Acurx Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | -170.3% | -170.3% | -142.7% |
| FY2021 | -102.7% | -102.7% | -96.2% |
| FY2022 | -165.3% | -165.3% | -129.0% |
| FY2023 | -312.4% | -312.4% | -189.1% |
| FY2024 | -2,292.7% | -2,292.7% | -365.6% |
| FY2025 | -151.2% | -151.2% | -103.6% |